10don MSN
'Molecular glue' stabilizes protein that inhibits development of non-small cell lung cancer
Lung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80% of lung ...
A large, multi-institution study led by a Brown University physician-scientist could have important implications for the development of new classes of cancer therapeutics.
Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets ...
A team at RMIT University in Melbourne say that extremely small metal particles – which they dub ‘nanodots’ – could be ...
Researchers demonstrated that newly developed molecules designed to block an immune checkpoint can trigger a powerful immune response against tumors. Scientists at MIT and Stanford University have ...
According to Japanese scientists, certain bacteria found in the digestive systems of frogs and lizards can completely ...
Increased stiffness of the colon, spurred by chronic inflammation, may encourage the development and progression of ...
Creating physiologically relevant conditions for cells that replicate in vivo environments can improve experimental results, ...
One of the biggest risk factors for developing liver cancer is a high-fat diet. A new study from MIT reveals how a fatty diet ...
5don MSN
Some mammals can hit pause on a pregnancy—understanding how that happens could help us treat cancer
Seals give birth only when conditions are right. After mating, a female seal can delay implantation of the embryo in the ...
News Medical on MSN
Johns Hopkins Scientists Develop Targeted Therapy for T-Cell Lymphomas and Leukemias
Researchers at the Johns Hopkins Kimmel Cancer Center’s Ludwig Center developed a new treatment that selectively targets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results